PELISH HENRY E. (Chief Scientific Officer) sold 3.2% of their position (2.11K shares) of NUVALENT, INC. on the open market
Open‑market sale worth $261.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/10/2026ACC: 0002029477-26-000008
Officer· Chief Scientific Officer
Since Mar 2026
-2.11K
Net shares
Net seller
$261.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.11K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−2.11K
Price / share
$123.81
Trade value
$261.36K
% of position
3.2%
7/9/2026
65.60K→63.49K
Total
Net shares
−2.11K
Net value
-$261.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 7/9/2026 | S · Sale | −2.11K | $123.81 | $261.36K | 3.2% | 65.60K | 63.49K |
| Total | −2.11K | -$261.36K | ||||||
Derivative Transactions0
No derivative transactions reported